Profile
Name
Invesco Biotechnology & Genome ETFAssets under management
$222 millionExpense ratio
0.50%Asset class
EquityDomicile
USInception date
June 23, 2005Net asset value
70K USDWebsite
http://www.invesco.comLast ex-dividend date
June 23, 2025Next ex-dividend date
N/ATop holdings
Name
Weight
5.16 %
4.97 %
4.92 %
4.83 %
4.82 %
4.70 %
4.65 %
4.64 %
3.98 %
3.64 %
3.48 %
3.28 %
3.11 %
2.82 %
2.80 %
2.76 %
2.72 %
2.70 %
2.66 %
2.57 %
2.54 %
2.53 %
2.50 %
2.46 %
2.46 %
2.45 %
2.44 %
2.40 %
2.40 %
2.35 %
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend per share
Dividend yield
Top holdings
Name
Weight
5.16 %
4.97 %
4.92 %
4.83 %
4.82 %
4.70 %
4.65 %
4.64 %
3.98 %
3.64 %
3.48 %
3.28 %
3.11 %
2.82 %
2.80 %
2.76 %
2.72 %
2.70 %
2.66 %
2.57 %
2.54 %
2.53 %
2.50 %
2.46 %
2.46 %
2.45 %
2.44 %
2.40 %
2.40 %
2.35 %
Analyst ratings
FAQ
- Does PBE pay dividends?
- What stocks are in PBE?
- What is the current assets under management for PBE?
- What is PBE average volume?
- What is PBE expense ratio?
- What is PBE inception date?
Does PBE pay dividends?
Yes, the Invesco Biotechnology & Genome ETF does pays dividends, with
the most recent payment being
$0.13
per share. The last ex-dividend date was on June 23, 2025, and the next ex-dividend date has not been announced yet
What stocks are in PBE?
As of today, Invesco Biotechnology & Genome ETF inlcudes 32 holdings, with 30 of them being companies from 1 different countries and 1 sectors. The most weighted holdings are Biogen Inc. (5.16%), Vertex Pharmaceuticals Incorporated (4.97%) and Royalty Pharma plc (4.92%)
What is the current assets under management for PBE?
Assets under management of Invesco Biotechnology & Genome ETF is $222M
What is PBE average volume?
Average volume of Invesco Biotechnology & Genome ETF is $8291
What is PBE expense ratio?
Expense ratio of Invesco Biotechnology & Genome ETF is 0.50%
What is PBE inception date?
Inception date of Invesco Biotechnology & Genome ETF is June 23, 2005